Skip to Main Content

Paper Details

Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.
Front Oncol
0
2023
Author NameAffiliation
Simeng SuyMedStar Georgetown University Hospital
Sean P CollinsMedStar Georgetown University Hospital
  • 1 - 2

Datasets

Release 1.2